Unlock instant, AI-driven research and patent intelligence for your innovation.

Eye drops to treat chemically induced corneal damage

a technology of eye drops and chemical induced corneal damage, which is applied in the direction of pharmaceutical delivery mechanism, drug composition, organic active ingredient, etc., can solve the problems of corneal damage, pain, irreversible blindness, and no therapy currently exists to counter sm's toxicity to the eye, and achieve the effect of effectively reducing nm-toxicity to the cornea

Pending Publication Date: 2021-05-06
UNIVERSITY OF MISSOURI +1
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

This patent describes a combination of nonsteroidal anti-inflammatory drugs (NSAIDs), histone deacetylase (HDAC) inhibitors, and angiotensin converting enzyme (ACE) inhibitors, and methods for using them to treat corneal damage and ocular toxicity. The technical effects of this invention include reducing inflammation, promoting corneal healing, and reducing ocular pressure.

Problems solved by technology

SM exposure causes severe corneal injury, pain, and irreversible blindness.
Despite a high risk of SM being used for terrorism, no therapy currently exists to counter SM's toxicity to the eye.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Eye drops to treat chemically induced corneal damage
  • Eye drops to treat chemically induced corneal damage
  • Eye drops to treat chemically induced corneal damage

Examples

Experimental program
Comparison scheme
Effect test

example 1

Acute MGK Pathology, Loss of Epithelial Barrier and Recurrent Corneal Epithelial Erosions, in Rabbits In Vivo by Topical TED

[0111]FIGS. 1A-1H show results of a clinical diagnostic Fluorescein eye test. This test is specific for reading loss of epithelial barrier and corneal erosions by gauging the area and density of green-dye uptake in the cornea, which tells extent of erosions and defects in corneal epithelium. SM contact to rabbit eyes showed dramatically increased epithelial erosion and deformations on day-3 (FIG. 1C) and day-7 (FIG. 1G) as pointed by the arrowheads compared to the naive (FIG. 1A, FIG. 1E) or TED-alone treated (FIG. 1B, FIG. 1F) eyes. Topical TED (twice daily for 5 days) on SM-exposed eyes prevented breach in epithelial barrier and erosions as no fluorescein uptake was noted on day-3 (FIG. 1D) or day-7 (FIG. 1H). Interestingly, 50% (3 out of 6) SM-exposed rabbit eyes showed recurring corneal epithelial erosion after 1-month (FIG. 2A) but none of SM+TED eyes at 1...

example 2

Other Acute MGK Symptoms

[0112]Remarkable mitigation of SM-induced epithelial-stromal disruption, basement membrane damage, and corneal edema was noted in human cornea ex vivo (FIG. 3A-3F) and rabbit eyes in vivo (FIG. 4A-4B) as shown by H&E and integrin-β4 immunostaining specific for the cornea. Rabbit eyes and human corneas in organ culture exposed to SM / NM were analyzed. In human cornea, ex vivo, vehicle (FIG. 3A, FIG. 3D) did not cause injury but nitrogen mustard (NM, 200 μM 30 s; SM-analog) exposure led to acute MGK (FIG. 3B, FIG. 3E). The NM+TED (twice daily for 5 days) treatments showed dramatic rescue of cornea from NM-injury (FIG. 3C, FIG. 3F). In rabbit eyes, in vivo, SM-exposed corneas showed hefty epithelial-stromal separation, basement membrane damage, and edema (FIG. 4A), and a remarkable mitigation of these pathologies was detected in SM+TED corneas (FIG. 4B). It is possible that LSCD and inflammatory cytokines play important role in producing these pathologies of acut...

example 3

n SM-Induced Acute MGK Pathology Involving Corneal Haze, Edema, and Tearing

[0113]Rabbit eyes were exposed to SM in + / −TED and live rabbits were examined with slit-lamp and stereo biomicroscopy, pachymetry, and Schirmer eye test in in a real-time manner. Clinical exams performed by 2 ophthalmologists and 1 cornea-scientist in a masked manner found no symptoms such as conjunctival hyperemia, uveitis, corneal opacity, recurrent epithelial defects, dry eye, or compromised intraocular pressure in naive (FIG. 5A, FIG. 5E, FIG. 5I) or TED-alone treated rabbit eyes (FIG. 5B, FIG. 5F, FIG. 5J) at day 3, day 7, or day 45. Conversely, SM-exposed rabbit eyes demonstrated a significantly high corneal haze and edema on day-3 (FIG. 5C), day-7 (FIG. 5G) and day-14 (FIG. 5K). Topical TED application on SM-vapor exposed eyes markedly reduced corneal haze (an acute MGK) on day-3 (FIG. 5D), on day-7 (FIG. 5H) and on day-14 (FIG. 5L) compared to corresponding-day SM-exposed rabbit eyes (FIG. 5C, FIG. 5G...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
temperatureaaaaaaaaaa
temperatureaaaaaaaaaa
compositionaaaaaaaaaa
Login to View More

Abstract

Provided herein are compositions suitable for treating chemically induced eye damage comprising (a) a nonsteroidal anti-inflammatory drug (NSAID), (b) a histone deacetylase (HDAC) inhibitor and (c) an angiotensin converting enzyme (ACE) inhibitor and, optionally, (d) a water-soluble vitamin. Methods of using provided compositions to treat ocular toxicity and corneal damage following exposure to chemical agents (e.g., mustard gas) are also provided.

Description

CROSS REFERENCE TO RELATED APPLICATIONS[0001]This application claims priority to U.S. Provisional Application No. 62 / 930,811 filed Nov. 5, 2019, which is incorporated herein by reference in its entirety.STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT[0002]This invention was made with Government support under grant number 1R21EY030234 awarded by the National Institutes of Health. The government has certain rights in the invention.FIELD OF THE INVENTION[0003]The present invention relates to a pharmaceutical composition for treating chemically induced corneal damage and methods of use thereof.BACKGROUND OF THE INVENTION[0004]Sulfur mustard gas (SM), a vesicating warfare agent, has been used in many wars since World War I including Iran-Iraq and most recently in Syria. SM exposure causes severe corneal injury, pain, and irreversible blindness. The cornea provides ⅔rd of the eye's refraction, and is vital for vision. SM, an alkylating agent, on contact to the eye rapidly ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K31/407A61K31/401A61K31/167A61K31/375A61P29/00A61K9/00
CPCA61K31/407A61K31/401A61K9/0048A61K31/375A61P29/00A61K31/167A61K45/06A61K2300/00
Inventor MOHAN, RAJIV R.
Owner UNIVERSITY OF MISSOURI